Straumann Holding AG (STMN.SW)
- Previous Close
134.40 - Open
132.30 - Bid 133.05 x --
- Ask 135.00 x --
- Day's Range
131.80 - 134.40 - 52 Week Range
97.00 - 151.50 - Volume
197,694 - Avg. Volume
210,947 - Market Cap (intraday)
21.222B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
85.87 - EPS (TTM)
1.55 - Earnings Date Feb 27, 2024
- Forward Dividend & Yield 0.85 (0.63%)
- Ex-Dividend Date Apr 16, 2024
- 1y Target Est
147.60
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
www.straumann.com10,554
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: STMN.SW
Performance Overview: STMN.SW
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STMN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STMN.SW
Valuation Measures
Market Cap
21.43B
Enterprise Value
21.43B
Trailing P/E
87.27
Forward P/E
42.55
PEG Ratio (5yr expected)
0.79
Price/Sales (ttm)
8.89
Price/Book (mrq)
11.67
Enterprise Value/Revenue
8.88
Enterprise Value/EBITDA
43.36
Financial Highlights
Profitability and Income Statement
Profit Margin
10.20%
Return on Assets (ttm)
11.05%
Return on Equity (ttm)
13.37%
Revenue (ttm)
2.41B
Net Income Avi to Common (ttm)
246.07M
Diluted EPS (ttm)
1.55
Balance Sheet and Cash Flow
Total Cash (mrq)
413.54M
Total Debt/Equity (mrq)
27.43%
Levered Free Cash Flow (ttm)
240.65M
Research Analysis: STMN.SW
Analyst Price Targets
Fair Value
No Fair Value available for this ticker